title: Experience with the treatment of metastatic ovarian carcinoma.
abstract: Metastases from non-genital sites comprise about one in six of our malignant ovarian tumors. The mean age of our 24 patients with such metastases was 43.1 years and 81% had bilateral ovarian metastases. Out of the 24 patients we studied, 21 had a gastric primary. The overall survival rate was 41.7% in 6 months, 25.0% in 1 year and 12.5% in 2 years. Patients with no extraovarian metastases had a survival rate of 75.0% at 6 months, 62.5% at 1 year and 25.0% at 2 years after operation.
authors.affiliation: Department of Obstetrics and Gynecology, University of Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Shiromizu
authors.forename: T
authors.initials: T
authors.lastname: Kawana
authors.forename: M
authors.initials: M
authors.lastname: Sugase
authors.forename: R
authors.initials: R
authors.lastname: Izumi
authors.forename: M
authors.initials: M
authors.lastname: Mizuno
mesh_terms: D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery; D011379:Prognosis